Enzo Life Sciences Diglycyl Lysine, mAb (GX41), monoclonal for ubiquitin remnant profiling
Identification of exact ubiquitinylation sites is challenging under physiological conditions, but the recent development of an immunoprecipitation approach allows for enrichment and identification of previously tagged peptides.
The Enzo Life Sciences Diglycyl Lysine, mAb (GX41), is a highly specific monoclonal for ubiquitin remnant profiling that recognises the diglycyl-lysine residue left behind after the ubiquitin itself is long gone - with no detectable reactivity to non-modified lysines.
Enzo offers a complete portfolio of products for ubiquitin research, including ubiquitin assays for isolation, enrichment and modification; ubiquitin and ubiquitin-like proteins; and ubiquitin and ubiquitin modification antibodies.
Phone: 02 4575 0309
Biosensis MAP2 antibodies
Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...
Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration
The antibodies are specific to CTC surface markers to enable the sensitive and specific...
Microbiologics UV-BioTAG QC microorganisms for quality control testing
UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...
Learn More
I am interested in Enzo Life Sciences Diglycyl Lysine, mAb (GX41), monoclonal for ubiquitin remnant profiling.
Complete the form and a supplier representative will be in touch.
